Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Tatva Chintan Pharma Chem Limited (NSE: TATVA), ISIN INE0GK401011 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
TATVA last traded at ₹1778.10 (+1.86%), with a 52-week range of ₹988.00 to ₹1838.85 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 72.02%, FIIs 3.93%, DIIs 3.11%, mutual funds 2.79%.
EquiSense Score (ECS): 89/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.